Radiopharm Theranostics (RADX) Intangibles (2024 - 2025)
Radiopharm Theranostics (RADX) has disclosed Intangibles for 2 consecutive years, with $46.6 million as the latest value for Q2 2025.
- Quarterly Intangibles fell 5.12% to $46.6 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $46.6 million through Jun 2025, down 5.12% year-over-year, with the annual reading at $46.6 million for FY2025, 5.12% down from the prior year.
- Intangibles for Q2 2025 was $46.6 million at Radiopharm Theranostics, down from $49.1 million in the prior quarter.
- The five-year high for Intangibles was $49.1 million in Q2 2024, with the low at $46.6 million in Q2 2025.